M.VollenhovenB.LolatgisN.HopeN.WongM.et al (2018)
The study did, however, also highlighted several negative side effects, including constipation (118 occurrences), diarrhea (100 events), and abdominal pain (41 events per 1,000) ( Abdominal pain, nausea, vomiting, and diarrhea are among the gastrointestinal adverse effects linked to GLP-1 RAs
How To Take: As a dietary supplement, take one packet 1 to 2 times per day or as directed by a healthcare practitioner
no significant effects on TMAO were exerted by training alone (paired samples Wilcoxon test, p = 0.173) or l-leucine supplementation (paired samples Wilcoxon test, p = 0.388) after six months (Figure 1)
Other gastrointestinal conditions, including gallbladder disease (cholelithiasis or cholecystitis), may coincide with therapy
Intersection of the ubiquitinproteasome system with oxidative stress in cardiovascular disease